Patent · US Active

Methods and compositions for inhibiting CD32B expressing cells

US8063187B2 · kind B2 · utility

109Cited by
28References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 2008
Grant dateNov 22, 2011
Priority date
Expiry dateMay 11, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to immunoglobulins that bind FcγRIIb+ cells and coengage the antigen on the cell's surface and an FcγRIIb on the cell's surface, methods for their generation, and methods for using the immunoglobulins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.